Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer Genomics and Diagnostics, RNA modifications and cancer, RNA and protein synthesis mechanisms, and RNA Research and Splicing.
Subtyping Burkitt Lymphoma by <scp>DNA</scp> Methylation
Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancer
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The <scp>CATCH</scp> experience
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response
Pipeline Olympics: continuable benchmarking of computational workflows for DNA methylation sequencing data against an experimental gold standard
Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
Molecular characterization of Richter syndrome identifies de novo diffuse large B-cell lymphomas with poor prognosis
Defining the landscape of circular RNAs in neuroblastoma unveils a global suppressive function of MYCN
Author Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
The genomic and transcriptional landscape of primary central nervous system lymphoma
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy
Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas
Abstract A010: Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC
T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic <scp>microRNAs</scp> on transcriptional and epigenetic level
Comprehensive Genomic and Transcriptomic Analysis for Guiding Therapeutic Decisions in Patients with Rare Cancers
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas
CATCH: A Prospective Precision Oncology Trial in Metastatic Breast Cancer
Multiomics reveal unique signatures of human epiploic adipose tissue related to systemic insulin resistance
Phylogeographic reconstruction of the marbled crayfish origin
Rare germline variants in the E-cadherin gene CDH1 are associated with the risk of brain tumors of neuroepithelial and epithelial origin
The genomic and transcriptional landscape of primary central nervous system lymphoma
The genomic and transcriptional landscape of primary central nervous system lymphoma
Splicing Endonuclease Is an Important Player in rRNA and tRNA Maturation in Archaea
Dauerhaftes Ansprechen auf Olaparib und endokrine Therapie bei einer Patientin mit metastasiertem luminalem Mammakarzinom und gBRCA-Mutation
COGNITION - Präzisionsmedizin bei Brustkrebs im Frühstadium
Abstract 821: Comprehensive genomic analysis of rare cancers: Results of the MASTER precision oncology trial of the German Cancer Consortium
Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma
The molecular landscape of ETMR at diagnosis and relapse